{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-379423","form_type":"8-K","ticker":"ALLO","cik":"0001737287","company_name":"Allogene Therapeutics, Inc.","filed_at":"2026-09-02T12:35:05+00:00","discovered_at":"2026-09-02T12:36:03.645031+00:00","generated_at":"2026-09-02T12:36:08.195517+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Allogene CFO Geoffrey Parker to retire effective Nov 6, 2026","bullets":["Geoffrey Parker, EVP and CFO, notified company of retirement on Aug 31, 2026.","Retirement effective November 6, 2026; he will depart in all capacities.","No successor named in the filing; company has not announced a replacement.","Parker served as principal financial officer; transition period of ~2 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-379423","json":"https://secwatch.observer/filing/0001193125-26-379423.json","markdown":"https://secwatch.observer/filing/0001193125-26-379423.md","text":"https://secwatch.observer/filing/0001193125-26-379423.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737287/000119312526379423/0001193125-26-379423-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737287/000119312526379423/d522964d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-02T12:36:08.195517+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}